Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Immunohistochemistry (IHC) Market Growth Performance Trended Historically, And What Lies Ahead?

Recent years have seen robust growth in the size of the immunohistochemistry (ihc) market. The market, which is projected to expand from $2.58 billion in 2024 to $2.76 billion in 2025, is set to experience a compound annual growth rate (CAGR) of 7.2%. This significant growth during the historic period can be attributed to factors such as clinical adoption, standardization in the industry, advancement in cancer research, automation in lab work, and progress in clinical diagnostics.

Rapid expansion is predicted for the immunohistochemistry (ihc) market in the coming years, with its size potentially reaching $4.07 billion by 2029, growing at a compound annual growth rate (CAGR) of 10.2%. This anticipated growth over the forecast period can be credited to elements like the introduction of new market players, the demand for drug creation, the incorporation of biomedical studies, applications in diagnostics, and the rise of automation and digitalization. Key trends to look for within this forecast period include techniques of multiplex IHC, integration of digital pathology, improvement in antibody specificity, automation, and standardization, along with its application in biomarker discovery.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9267&type=smp

What External and Internal Drivers Are Contributing to the Growth of theImmunohistochemistry (IHC) Market?

The proliferation of chronic illnesses is anticipated to fuel the growth of the immunohistochemistry (IHC) market. Chronic diseases are medical conditions that persist for an extended period of three months or more and generally can be managed but not completely cured. IHC plays a significant part in the diagnosis of these chronic conditions, including cancer and cardiovascular disorders, due to its plethora of benefits, including specificity, sensitivity (particularly in detecting specific antigens), swift results, among others. For instance, the Centers for Disease Control and Prevention, a reputed public health agency in the US, reported in 2022 that approximately 37.3 million people, representing 11.3% of the US population, are living with diabetes. Accordingly, the rise in chronic disease occurrence is propelling the expansion of the IHC market.

What Segment Types Define the Immunohistochemistry (IHC) Market Structure?

The immunohistochemistry (ihc)market covered in this report is segmented –

1) By Product: Antibodies, Equipment, Reagents, Kits

2) By Applications: Diagnostics, Drug Testing, Other Applications

3) By End-Users: Hospitals And Diagnostic Laboratories, Research Institutes, Other End-Users

Subsegments:

1) By Antibodies: Primary Antibodies, Secondary Antibodies, Conjugated Antibodies

2) By Equipment: IHC Staining Systems, Tissue Processors, Slide Scanners, Microscopes

3) By Reagents: Detection Reagents, Blocking Reagents, Mounting Media

4) By Kits: Pre-prepared IHC Kits, Multiplex IHC Kits, Specialty Kits

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=9267&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Immunohistochemistry (IHC) Market?

North America was the largest region in the immunohistochemistry (IHC) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the immunohistochemistry (IHC) market report during the forecast period. The regions covered in the immunohistochemistry (IHC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Long-Term Trends Are Transforming the Competitive Landscape of the Immunohistochemistry (IHC) Market?

Significant players in the immunohistochemistry (IHC) market are concentrating on improving diagnostic accuracy using innovative technologies and high-quality reagents in order to boost the efficacy of tissue analysis in various clinical and research contexts. The Neoflex multiomics mass spectrometry imaging (MSI) system is a state-of-the-art imaging platform structured for accurate tissue analysis, facilitating researchers to shift from discovery to clinical applications utilizing high-resolution mass spectrometry methods, particularly for topographically mapping biomolecules in tissues. For instance, Bruker Corporation, a US-based firm known for developing and manufacturing scientific instruments and analytical and diagnostic solutions, in June 2024, introduced its matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF/TOF) Neoflex Imaging Profiler designed for mass spectrometry-based tissue imaging. The Neoflex multiomics MSI system caters to the need of moving from discovery imaging to clinical tissue study. It is equipped with Bruker’s 10-kHz smartbeam 3D laser, enhanced imaging detectors, and is compatible with OME-TIFF file output using SCiLS Scope software.

View the full report here:

https://www.thebusinessresearchcompany.com/report/immunohistochemistry-ihc-global-market-report

What Is the Definition of the Immunohistochemistry (IHC) Market?

Immunohistochemistry (IHC) is the technique in diagnosis that uses antibody-antigen interaction to locate particular proteins and antigens in the tissue section. This interaction is visualized using chromogenic detection using enzyme-substrate or fluorescent detection using fluorescent dye.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9267

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model